Ubrogepant T17194
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ubrogepant is a novel oral calcitonin gene-related peptide receptor antagonist in development for acute treatment of migraine.
CAS nr:
1374248-77-7
Purity:
98%
Molecular Weight:
549,54
SMILES:
O=C(C1=CN=C2C(C[C@@]3(C4=CC=CN=C4NC3=O)C2)=C1)N[C@@H]5C(N(CC(F)(F)F)[C@H](C)[C@H](C6=CC=CC=C6)C5)=O
Formula:
C29H26F3N5O3
Pathway:
Others
Target:
Others
